Advertisement
Screener

THE PENNANT GROUP, INC. (PNTG) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

THE PENNANT GROUP, INC. Investing Cash Flow

THE PENNANT GROUP, INC. (PNTG) reported Investing Cash Flow of -$45.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05

  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$39.92M.
  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$5.38M.
  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$153.02M.
  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$14.60M.
  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$227.97M.
  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$70.68M.
  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$30.22M.
  • THE PENNANT GROUP, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$24.24M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$39.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$45.30M
10-Q · filed 2026-08-05
-$198.32M
derived: sum of 3 quarters · filed 2026-08-05
-$212.92M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$5.38M
10-Q · filed 2026-05-06
-$158.40M
derived: sum of 2 quarters · filed 2026-05-06
-$173.00M
derived: sum of 3 quarters · filed 2026-05-06
-$183.05M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$153.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$167.62M
derived: sum of 2 quarters · filed 2026-02-26
-$177.67M
derived: sum of 3 quarters · filed 2026-08-05
-$227.97M
10-K · filed 2026-02-26
2025-09-30-$14.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$24.65M
derived: sum of 2 quarters · filed 2026-08-05
-$74.95M
10-Q · filed 2025-11-05
-$79.35M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$10.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$60.35M
10-Q · filed 2026-08-05
-$64.75M
derived: sum of 3 quarters · filed 2026-08-05
-$97.76M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$50.30M
10-Q · filed 2026-05-06
-$54.70M
derived: sum of 2 quarters · filed 2026-05-06
-$87.70M
derived: sum of 3 quarters · filed 2026-05-06
-$97.35M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$4.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$37.40M
derived: sum of 2 quarters · filed 2026-02-26
-$47.05M
derived: sum of 3 quarters · filed 2026-02-26
-$70.68M
10-K · filed 2026-02-26
2024-09-30-$33.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$42.65M
derived: sum of 2 quarters · filed 2025-11-05
-$66.29M
10-Q · filed 2025-11-05
-$78.93M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$9.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$33.28M
10-Q · filed 2025-08-06
-$45.93M
derived: sum of 3 quarters · filed 2026-02-26
-$52.28M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$23.64M
10-Q · filed 2025-05-06
-$36.28M
derived: sum of 2 quarters · filed 2026-02-26
-$42.63M
derived: sum of 3 quarters · filed 2026-02-26
-$51.53M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$12.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$19.00M
derived: sum of 2 quarters · filed 2026-02-26
-$27.90M
derived: sum of 3 quarters · filed 2026-02-26
-$30.22M
10-K · filed 2026-02-26
2023-09-30-$6.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$15.25M
derived: sum of 2 quarters · filed 2024-11-06
-$17.58M
10-Q · filed 2024-11-06
-$21.64M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$8.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$11.23M
10-Q · filed 2024-08-06
-$15.29M
derived: sum of 3 quarters · filed 2025-02-27
-$26.71M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$2.33M
10-Q · filed 2024-05-06
-$6.39M
derived: sum of 2 quarters · filed 2025-02-27
-$17.82M
derived: sum of 3 quarters · filed 2025-02-27
-$23.98M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$4.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$15.49M
derived: sum of 2 quarters · filed 2025-02-27
-$21.66M
derived: sum of 3 quarters · filed 2025-02-27
-$24.24M
10-K · filed 2025-02-27
2022-09-30-$11.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$17.59M
derived: sum of 2 quarters · filed 2023-11-07
-$20.18M
10-Q · filed 2023-11-07
-$22.23M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$6.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$8.75M
10-Q · filed 2023-08-08
-$10.80M
derived: sum of 3 quarters · filed 2024-02-28
-$13.39M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$2.58M
10-Q · filed 2023-05-04
-$4.64M
derived: sum of 2 quarters · filed 2024-02-28
-$7.22M
derived: sum of 3 quarters · filed 2024-02-28
-$18.71M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$2.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$4.64M
derived: sum of 2 quarters · filed 2024-02-28
-$16.13M
derived: sum of 3 quarters · filed 2024-02-28
-$20.12M
10-K · filed 2024-02-28
2021-09-30-$2.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$14.07M
derived: sum of 2 quarters · filed 2022-11-07
-$18.07M
10-Q · filed 2022-11-07
-$32.10M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30-$11.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$15.48M
10-Q · filed 2022-08-08
-$29.52M
derived: sum of 3 quarters · filed 2023-02-23
-$43.29M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$4.00M
10-Q · filed 2022-05-09
-$18.03M
derived: sum of 2 quarters · filed 2023-02-23
-$31.81M
derived: sum of 3 quarters · filed 2023-02-23
-$38.84M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31-$14.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
-$27.81M
derived: sum of 2 quarters · filed 2023-02-23
-$34.84M
derived: sum of 3 quarters · filed 2023-02-23
-$41.62M
10-K · filed 2023-02-23
2020-09-30-$13.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
-$20.81M
derived: sum of 2 quarters · filed 2021-11-08
-$27.58M
10-Q · filed 2021-11-08
-$31.54M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$7.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$13.80M
10-Q · filed 2021-08-09
-$17.76M
derived: sum of 3 quarters · filed 2022-02-28
-$21.70M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$6.77M
10-Q · filed 2021-05-06
-$10.73M
derived: sum of 2 quarters · filed 2022-02-28
-$14.67M
derived: sum of 3 quarters · filed 2022-02-28
-$30.67M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31-$3.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$7.90M
derived: sum of 2 quarters · filed 2022-02-28
-$23.90M
derived: sum of 3 quarters · filed 2022-02-28
-$26.46M
10-K · filed 2022-02-28
2019-09-30-$3.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
-$19.94M
derived: sum of 2 quarters · filed 2020-11-10
-$22.51M
10-Q · filed 2020-11-10
-$26.44M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30-$16.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$18.57M
10-Q · filed 2020-08-11
-$22.50M
derived: sum of 3 quarters · filed 2021-02-24
2019-03-31-$2.56M
10-Q · filed 2020-05-13
-$6.50M
derived: sum of 2 quarters · filed 2021-02-24
2018-12-31-$3.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
-$9.48M
10-K · filed 2021-02-24
2018-09-30-$5.54M
10-Q · filed 2019-11-12
2017-12-31-$16.08M
10-K · filed 2020-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86